Replies to post #372867 on Amarin Corp Plc (AMRN)

[lizzy241]

bidmark, Ekman may own options cause he's COB he also receives some kind of monetary compensation. SEC website is down so I can't retrieve the last proxy. I'll search amarin's website instead.
His firm doesn't own shares according to their filings.

[Retired2019]

Bidmark,

Hello. I have no knowledge of that.

[lizzy241]

bidmark,
here you go, compensation for our do nothing BOD!!!!

In addition, on July 13, 2020, the Company awarded an option to purchase 36,739 ordinary shares and 28,702 restricted stock units to Dr. Ekman in connection with his service on the Board and as Non-Executive Chairman of the Board. The option vests in full upon the earlier of the one-year anniversary of the grant date or the Company’s 2021 Annual General Meeting, while the restricted stock units vest in equal annual installments over three years, in each case upon the earlier of the anniversary of the date of grant or the annual general meeting of shareholders in such anniversary year, commencing in 2021. The total grant-date fair value of each of these awards is approximately $190,000, based on a closing price of $6.62 on Nasdaq of the ADSs representing the Company’s Ordinary Shares on the date of grant.

Director Compensation Table

The following table shows the compensation paid in fiscal year 2020 to the Company’s non-employee directors;



Name

Fees
Earned or
Paid in
Cash
($) Stock
Awards(1)(3)
($) Option
Awards(2)(3)
($) Other(4)
($) Total ($)
Lars G. Ekman, M.D., Ph.D.

100,000 190,007 190,005 971,183 1,451,195
Patrick J. O’Sullivan

85,500 180,004 180,002 — 445,506
Kristine Peterson

84,500 180,004 180,002 324,208 768,714
David Stack

82,500 180,004 180,002 437,402 879,908
Jan van Heek

97,500 180,004 180,002 392,748 850,254
Joseph S. Zakrzewski

67,500 180,004 180,002 — 427,506


(1)
The value of the stock awards reflects the aggregate grant date fair value, calculated in accordance with FASB ASC 718, excluding the effect of estimated forfeitures. Assumptions used in the calculations for these amounts are set forth in Note 11 to our financial statements included in our Annual Report on Form 10-K filed with the SEC on February 25, 2021.

(2)
The value of the option awards reflects the aggregate grant date fair value, calculated in accordance with FASB ASC 718 using the Black-Scholes option-pricing model, excluding the effect of estimated forfeitures. Assumptions used in the calculations for these amounts are set forth in Note 11 to our financial statements included in our Annual Report on Form 10-K filed with the SEC on February 25, 2021.



59

Table of Contents